Tokai Research and Development No. 1 Investment Limited Partnership

All recorded activity

By stage

Series B1

Biotech1

Japan1

1 in all activity

Sep 4

A clinical-stage biotechnology company developing microbiome-based therapies using fecal microbiota transplantation.

¥190MSeries B extension (first close)

Participant